全文获取类型
收费全文 | 3528篇 |
免费 | 357篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 55篇 |
儿科学 | 122篇 |
妇产科学 | 55篇 |
基础医学 | 427篇 |
口腔科学 | 162篇 |
临床医学 | 369篇 |
内科学 | 630篇 |
皮肤病学 | 29篇 |
神经病学 | 464篇 |
特种医学 | 206篇 |
外科学 | 320篇 |
综合类 | 55篇 |
一般理论 | 1篇 |
预防医学 | 282篇 |
眼科学 | 79篇 |
药学 | 306篇 |
中国医学 | 2篇 |
肿瘤学 | 323篇 |
出版年
2021年 | 35篇 |
2020年 | 24篇 |
2019年 | 43篇 |
2018年 | 51篇 |
2017年 | 34篇 |
2016年 | 50篇 |
2015年 | 53篇 |
2014年 | 84篇 |
2013年 | 122篇 |
2012年 | 165篇 |
2011年 | 137篇 |
2010年 | 113篇 |
2009年 | 81篇 |
2008年 | 164篇 |
2007年 | 154篇 |
2006年 | 170篇 |
2005年 | 153篇 |
2004年 | 153篇 |
2003年 | 131篇 |
2002年 | 131篇 |
2001年 | 137篇 |
2000年 | 106篇 |
1999年 | 101篇 |
1998年 | 56篇 |
1997年 | 56篇 |
1996年 | 48篇 |
1995年 | 61篇 |
1994年 | 51篇 |
1993年 | 55篇 |
1992年 | 64篇 |
1991年 | 72篇 |
1990年 | 73篇 |
1989年 | 71篇 |
1988年 | 75篇 |
1987年 | 76篇 |
1986年 | 72篇 |
1985年 | 57篇 |
1984年 | 46篇 |
1983年 | 41篇 |
1982年 | 32篇 |
1981年 | 23篇 |
1979年 | 33篇 |
1978年 | 41篇 |
1977年 | 37篇 |
1976年 | 33篇 |
1975年 | 26篇 |
1974年 | 25篇 |
1971年 | 24篇 |
1970年 | 33篇 |
1968年 | 22篇 |
排序方式: 共有3887条查询结果,搜索用时 140 毫秒
1.
D Gröne† R Treudler† EM de Villiers‡ R Husak† CE Orfanos† ChC Zouboulis†§ 《Journal of the European Academy of Dermatology and Venereology》2006,20(2):202-205
Cidofovir is an acyclic nucleoside phosphonate with broad-spectrum activity against DNA viruses, including human papilloma virus (HPV). However, data on the efficacy of cidofovir in an immunosuppressive setting remain contradictory. We report for the first time on the promotion of the healing of recalcitrant warts in a patient with myelodysplastic syndrome with intravenous cidofovir treatment. 相似文献
2.
One of the important steps on the road to becoming expert in a motor skill occurs when the individual can perform the movements in a seemingly effortless and automatic fashion. The authors review two lines of investigations, namely, fMRI and mathematically guided studies of the dynamics of skill acquisition, that suggest that this road to automatic involves two steps: (1) an increasing reliance on the self-regulatory aspects of the motor task, and (2) a minimization of the role of mechanisms based on intentionally directed corrective movements. The interplay between these two mechanisms implies that, at a given skill level, performance decreases whenever intention intervenes. The observation that psychological factors may be as important as mechanical repetition for the development of expertise has important implications for the design of neurorehabilitative strategies. 相似文献
3.
AIM: To assess the efficacy of intravesical botulinum toxin type A (BTX-A) in interstitial cystitis (IC). METHODS: Eleven patients with IC were injected with BTX-A. Primary outcome measures were: Bristol Female Lower Urinary Tract Symptom Score, Kings Health Questionnaire and 24-hour frequency-volume chart. They had urodynamics done before and six weeks after injection. Detrusor contractility was assessed using the modified PIP1 (projected isovolumetric detrusor pressure). 相似文献
4.
5.
Over the past several years, increased interest in preventing youth problems and promoting healthy youth development has led youth and family practitioners, policy makers, and researchers to develop a wide range of approaches based on various theoretical frameworks. Although the growth in guiding frameworks has led to more complex models and a greater diversity in the options available to scholars and practitioners, the lack of an integrative conceptual scheme and consistent terminology has led to some confusion in the field. Here, we provide an overview of three approaches to youth development and problem prevention, critically examine their strengths and weaknesses, and offer some elaborations to help clarify, extend, and integrate the models. We conclude by discussing some general implications for researchers, practitioners, and policy makers. 相似文献
6.
7.
8.
Dr. Barbara McGee Hughes Pharm.D. Dr. Ralph E. Small Pharm.D. Dr. Douglas Brink Pharm.D. Dr. Norma D. McKenzie M.D. 《Pharmacotherapy》1997,17(1):113-120
Study Objective . To evaluate the effects of flurbiprofen therapy on the pharmacokinetics of lithium. Design . Placebo-controlled, single-blind, crossover study. Setting . University-affiliated hospital. Patients . Eleven healthy women with bipolar disorder. Interventions . The subjects received therapeutic doses of lithium administered as an immediate-release capsule every 12 hours. In addition, they received one placebo tablet every 12 hours during phase I and flurbiprofen 100 mg every 12 hours during phase II of the study. Measurements and Main Results . Steady-state pharmacokinetic parameters were measured for each phase. Lithium trough plasma concentration (Cmin) and area under the curve were statistically significantly increased (p<0.05) when patients received flurbiprofen. Flurbiprofen also caused decreases in lithium clearance and 24-hour lithium urine excretion, although the changes did not reach statistical significance. Clinically significant increases in Cmin appeared to be associated with a greater than 1000-μg/24 hour decrease in urinary excretion of prostaglandin E2. Conclusion . Patients with clinically normal renal function may experience an increase in lithium levels with the initiation of flurbiprofen therapy. 相似文献
9.
Mesalamine is the therapeutically active moiety of sulfasalazine used to treat inflammatory bowel disease. A controlled-release mesalamine capsule (Pentasa) is designed to release the agent continuously, and largely unaffected by intestinal pH, throughout the small and large bowel due to a diffusion-dependent, semipermeable ethylcellulose coating. It is a safe and efficacious single agent for inducing remission and producing therapeutic benefit in patients with mild to moderately active ulcerative colitis (UC) (2 or 4 g/day) or Crohn's disease (4 g/day), as well as for significantly enhancing quality of life for patients with mild to moderately active UC (2 or 4 g/day). It is also effective for maintaining remission in patients with quiescent UC and Crohn's disease (4 g/day). Disease location (left-sided UC or pancolitis) did not affect the agent's effect in active disease or maintaining remission. Fewer treatment-related adverse events were reported with mesalamine than with placebo in treating UC. In the treatment of active Crohn's disease, data showed no statistically significant differences in response for patients with ileitis, ileocolitis, or Crohn's colitis. This formulation of mesalamine may also be a possible steroid-sparing agent for patients with either active or quiescent Crohn's disease. 相似文献
10.